We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Diagnostics

Image: Three presentations will examine Arima Genomics’ high-throughput Hi-C sequencing technology in salivary gland cancer, triple-negative breast cancer, and aggressive cutaneous T-cell lymphoma (Photo courtesy of Arima Genomics)

New Research Examines Hi-C Sequencing Across Solid Tumors and Lymphoma

Arima Genomics will present new research on its Aventa FusionPlus and Aventa Lymphoma tests at AMP 2026. More...
09 Nov 2026
Image Credit: Adobe Stock

Comprehensive Tumor Profiling Uncovers Overlooked Hereditary Cancer Risk Genes

NGS tumor profiling uncovers germline cancer risk variants missed by guidelines, supporting treatment and cascade testing. More...
06 Nov 2026
Image: The EsoCheck balloon capsule device including Collect + Protect™ technology (Image: Smith MS, et al. Diagnostics. 2026;16(21):3566, https://doi.org/10.3390/diagnostics16213566)

Nonendoscopic Methylation Assay Enables Rapid Barrett’s Esophagus Screening

New data show a nonendoscopic DNA test for Barrett's esophagus is rapid, well tolerated, and scalable across operators. More...
06 Nov 2026
Image: Post-treatment surveillance of head and neck squamous cell carcinoma remains challenging because conventional methods, including imaging, can have low sensitivity and high false-positive rates. (Image Credit: Adobe Stock)

Studies Support MRD Testing to Detect Head and Neck Cancer Recurrence

Natera’s Signatera was evaluated for MRD detection, recurrence surveillance, and prediction of chemotherapy benefit in head and neck squamous cell carcinoma. More...
06 Nov 2026
Image:(L to R) Co-first author Yuan Feng, PhD, corresponding author Xiaotu Ma, PhD, and co-first author Hanxia Li, PhD, all of the St. Jude Department of Computational Biology. (Photo courtesy of St. Jude Children\'s Research Hospital)

Genomic Profiling Predicts Relapse Risk by Subtype in Pediatric Leukemia

New findings show subtype-specific genomic changes at diagnosis flag relapse risk in childhood B-ALL to refine stratification. More...
05 Nov 2026
Image Credit: Adobe Stock

AI-Supported Approach May Improve Cervical Cancer Screening in Low-Resource Settings

An AI approach combining self-collected HPV testing with image analysis improves detection of high-grade cervical precancer in low-resource settings. More...
04 Nov 2026
Image: Overview of the neural network architecture and training. (Stefan, S., Amann, A.S., Smith, K.S. et al. AI-based precision prognostics and therapy personalization for childhood brain tumors. Nature Genetics (2026). https://doi.org/10.1038/s41588-026-02815-4)

Molecular AI Model Refines Risk Prediction in Pediatric Brain Tumors

An AI approach using methylation data personalizes survival prediction in pediatric brain tumors and outperforms risk models. More...
04 Nov 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.